Progen Pharmaceuticals

Home

Latest news
Email alerts
Fact sheets
Presentations

Our Company

Our vision
Company summary
Our board of directors
Our management team
Contacts

Our Technology

Our technology
Angiogenesis
Cell proliferation
Epigenetics
Publications
Presentations
Gloassary

Our Pipeline

Angiogenesis
PG545
Heparanase program
Cell proliferation
PG11047 monotherapy (solid tumors)
PG11047 combination (solid tumors)
PG11000 series
Polyamine
Epigenetics
Epigenetics series
Study Information
 

Investor Centre

IR summary
Newsletter
Email alerts
Reports
Corporate presentations
ASX announcements
ASX shareholder centre
NASDAQ shareholder centre
Corporate governance
Top holders
FAQ
Contacts
Home Our Company Our Technology Our Pipeline Investor Centre